α2-Adrenoceptor and dopamine D2-receptor agonist. Prepn: G. Griss et al., DE 2040510 (1972 to Thomae); eidem, US 3804849 (1974 to Boehringer, Ing.). Dopaminergic effects: P. A. Johansen et al., Life Sci. 43, 515 (1988); S. K. Kulkarni, K. Chopra, Methods Find. Exp. Clin. Pharmacol. 12, 99 (1990). Clinical evaluation in Parkinson's disease: Y. Mizuno et al., Drug Invest. 5, 186 (1993).
Antiparkinsonian.
α-Adrenergic Agonist; Antiparkinsonian; Dopamine Receptor Agonist